ACRF Blood Cancer Therapeutics Centre
The ACRF Blood Cancer Therapeutics Centre, based at The Alfred, will be home to the latest technology available in blood cancer research and will enable researchers to dramatically improve outcomes for patients with blood cancer.
Each year, 11,500 Australians are diagnosed with blood cancer, including leukaemia, lymphoma and myeloma. Sadly, these debilitating diseases – which account for one in 10 cancers diagnosed nationally – claim 4000 lives every year.
The new centre will enable researchers to find out more about these cancers – including why some treatments work for some people and others don’t – and develop new ways to treat them.
“Many of our patients with various forms of blood cancer have had great success in clinical trials, which use new and unique drug combinations,” Dr Wei said.
The flagship centre will collect samples from across the country.
Utilising the most up to date technology available, this new centre will enable us to discover more effective therapies, track patient treatment responses up to 1000 times more closely, and improve therapies to get better outcomes overall for patients.
Chief Investigators: Dr Andrew Wei and Dr Andrew Spencer